Abatacept-based approach to cure of RA
Not Applicable
Recruiting
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000008756
- Lead Sponsor
- niversity of Occupational and Environmental Health, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1,Contraindication with abatacept 2, Patients treated with abatacept 3, Using PSL, plasma pheresis, joint replacement and other surgical treatment 4 Chronic active EBV infection 5,Chronic HBV infection 6, Infection 7, Patients who are pregnant, who are nursing or who hope to be pregnant 8, Patients who are inadequate by investigator's decision.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does abatacept target in rheumatoid arthritis to achieve disease modification?
How does abatacept compare to TNF inhibitors in long-term remission rates for rheumatoid arthritis patients?
Which biomarkers correlate with response to abatacept therapy in Japanese RA populations?
What are the safety profiles of abatacept-based regimens in combination with methotrexate for RA treatment?
How does abatacept's co-stimulatory modulation compare to other immunosuppressive approaches in rheumatoid arthritis?